Qin, Angel
Gadgeel, Shirish
Funding for this research was provided by:
National Institutes of Health (5T32CA009357-35)
Article History
First Online: 31 August 2017
Compliance with Ethical Standards
:
: Angel Qin is supported by the National Institute of Health Oncology Research Training Grant 5T32CA009357-35.
: Angel Qin has no conflicts of interest to declare. Shirish Gadgeel has received consulting fees or honorarium from Genentech/Roche, Ariad, Pfizer, Novartis, and Astra-Zeneca.